Molecular RHD screening of RhD negative donors can replace standard serological testing for RhD negative donors

Transfusion and Apheresis Science

Volumn 50, Issue 2, 2014, Pages 163-168

  Gowland, Peter ^a   Gassner, Christoph ^b   Hustinx, Hein ^a   Stolz, Martin ^a   Gottschalk, Jochen ^b   Tissot, Jean Daniel ^c   Thierbach, Jutta ^d   Maier, Andreas ^e   Sigurdardottir, Sonja ^b   Still, Franziska ^a   Fontana, Stefano ^a   Frey, Beat M ^b   Niederhauser, Christoph ^a  

^a Blood Transfusion Service SRC Berne   (Switzerland)

^b Zurich Blood Transfusion Service SRC   (Switzerland)

^c Vaud Regional Blood Transfusion Service   (Switzerland)

^d Blood Transfusion Service SRC Nordost Schweiz   (Switzerland)

^e Blood Transfusion Service SRC Central Switzerland   (Switzerland)

Author keywords

IAT; Molecular RHD screening; RhD

Indexed keywords

RHESUS D ANTIGEN; BLOOD GROUP RHESUS SYSTEM; RHO(D) ANTIGEN;

ADSORPTION; ANTIGEN EXPRESSION; BLOOD DONOR; BLOOD GROUP RHESUS SYSTEM; BLOOD TRANSFUSION; CONTROLLED STUDY; COOMBS TEST; DENSITY; ELUTION; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; REVIEW; SCREENING; ALLELE; BLOOD GROUP TYPING; DONOR SELECTION; FEMALE; GENETICS; GENOTYPING TECHNIQUE; MALE; PHENOTYPE; PROCEDURES;

ALLELES; BLOOD GROUPING AND CROSSMATCHING; DONOR SELECTION; FEMALE; GENOTYPING TECHNIQUES; HUMANS; MALE; PHENOTYPE; RH-HR BLOOD-GROUP SYSTEM;

EID: 84900471678     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2014.02.009     Document Type: Review

References (30)

1. ISBT. Committee on terminology for RBC surface antigens; 2012. <>. http://wwwisbtweborg/working-parties/red-cell-immunogenetics-and-blood-group-terminology.
2. Filbey D., Hanson U., Wesstrom G. The prevalence of red cell antibodies in pregnancy correlated to the outcome of the newborn: a 12 year study in central Sweden. Acta obstetricia et gynecologica Scandinavica 1995, 74:687-692.
3. Whitfield C.R., Raafat A., Urbaniak S.J. Underreporting of mortality from RhD haemolytic disease in Scotland and its implications: retrospective review. BMJ 1997, 315:1504-1505.
4. Daniels G. Human bood groups. 3rd ed. Blackwell Science; 2013.
5. Wagner F.F., Flegel W.A. RHD gene deletion occurred in the Rhesus box. Blood 2000, 95:3662-3668.
6. Wagner F.F., Frohmajer A., Flegel W.A. RHD positive haplotypes in D negative Europeans. BMC Genet 2001, 2:10.
7. Gassner C., Doescher A., Drnovsek T.D., Rozman P., Eicher N.I., Legler T.J., et al. Presence of RHD in serologically D-, C/E+ individuals: a European multicenter study. Transfusion 2005, 45:527-538.
8. Flegel W.A. Homing in on D antigen immunogenicity. Transfusion 2005, 45:466-468.
9. Wagner T., Kormoczi G.F., Buchta C., Vadon M., Lanzer G., Mayr W.R., et al. Anti-D immunization by DEL red blood cells. Transfusion 2005, 45:520-526.
10. Yasuda H., Ohto H., Sakuma S., Ishikawa Y. Secondary anti-D immunization by Del red blood cells. Transfusion 2005, 45:1581-1584.
11. Avent N.D., Martinez A., Flegel W.A., Olsson M.L., Scott M.L., Nogues N., et al. The Bloodgen Project of the European Union, 2003-2009. Transfusion Medicine and Hemotherapy: Offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie. 2009, 36:162-167.
12. Flegel W.A., von Zabern I., Wagner F.F. Six years' experience performing RHD genotyping to confirm D-red blood cell units in Germany for preventing anti-D immunizations. Transfusion 2009, 49:465-471.
13. Polin H., Danzer M., Hofer K., Gassner W., Gabriel C. Effective molecular RHD typing strategy for blood donations. Transfusion 2007, 47:1350-1355.
14. Polin H., Danzer M., Gaszner W., Broda D., St-Louis M., Proll J., et al. Identification of RHD alleles with the potential of anti-D immunization among seemingly D-blood donors in Upper Austria. Transfusion 2009, 49:676-681.
15. Christiansen M., Sorensen B.S., Grunnet N. RHD positive among C/E+ and D-blood donors in Denmark. Transfusion 2010, 50:1460-1464.
16. Kormoczi G.F., Gassner C., Shao C.P., Uchikawa M., Legler T.J. A comprehensive analysis of DEL types: partial DEL individuals are prone to anti-D alloimmunization. Transfusion 2005, 45:1561-1567.
17. Gassner C., Schmarda A., Kilga-Nogler S., Jenny-Feldkircher B., Rainer E., Muller T.H., et al. RHD/CE typing by polymerase chain reaction using sequence-specific primers. Transfusion 1997, 37:1020-1026.
18. Legler T.J., Maas J.H., Köhler M., Wagner T., Daniels G.L., Perco P., et al. RHD sequencing: a new tool for decision making on transfusion therapy and provision of Rh prophylaxis. Transfus Med 2001, 11:383-388.
19. Flegel W.A., Eicher N.I., Doescher A., Hustinx H., Gowland P., Mansouri Taleghani B., et al. In-frame triplet deletions in RHD alter the D antigen phenotype. Transfusion 2006, 46:2156-2161.
20. Singleton B.K., Green C.A., Avent N.D., Martin P.G., Smart E., Daka A., et al. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in africans with the Rh D-negative blood group phenotype. Blood 2000, 95:12-18.
21. Cruz B.R., Chiba A.K., Moritz E., Bordin J.O. RHD alleles in Brazilian blood donors with weak D or D-negative phenotypes. Transfus Med 2012, 22:84-89.
22. Silvy M., Chapel-Fernandes S., Callebaut I., Beley S., Durousseau C., Simon S., et al. Characterization of novel RHD alleles: relationship between phenotype, genotype, and trimeric architecture. Transfusion 2012, 52:2020-2029.
23. Pham B.N., Peyrard T., Juszczak G., Dubeaux I., Gien D., Blancher A., et al. Heterogeneous molecular background of the weak C, VS+, hr B-, Hr B-phenotype in black persons. Transfusion 2009, 49:495-504.
24. Fichou Y., Chen J.M., Le Marechal C., Jamet D., Dupont I., Chuteau C., et al. Weak D caused by a founder deletion in the RHD gene. Transfusion 2012.
25. Har antigen complex is associated with a limited number of D epitopes and alloanti-D production: a study of three unrelated persons and their families. Transfusion 1996, 36:104-108.
26. Li Q., Hou L., Guo Z.H., Ye L.Y., Yue D.Q., Zhu Z.Y. Molecular basis of the RHD gene in blood donors with DEL phenotypes in Shanghai. Vox Sanguinis 2009, 97:139-146.
27. Wagner F.F., Frohmajer A., Ladewig B., Eicher N.I., Lonicer C.B., Muller T.H., et al. Weak D alleles express distinct phenotypes. Blood 2000, 95:2699-2708.
28. Kormoczi G.F., Forstemann E., Gabriel C., Mayr W.R., Schonitzer D., Gassner C. Novel weak D types 31 and 32: adsorption-elution-supported D antigen analysis and comparison to prevalent weak D types. Transfusion 2005, 45:1574-1580.
29. Ansart-Pirenne H., Asso-Bonnet M., Le Pennec P.Y., Roussel M., Patereau C., Noizat-Pirenne F. RhD variants in Caucasians: consequences for checking clinically relevant alleles. Transfusion 2004, 44:1282-1286.
30. Kormoczi G.F., Legler T.J., Daniels G.L., Green C.A., Struckmann R., Jungbauer C., et al. Molecular and serologic characterization of DWI, a novel "high-grade" partial D. Transfusion 2004, 44:575-580.